Health

Hippocratic AI, a generative AI company developing safety-focused large language models for healthcare, announced the appointment of seven new executives following the closing of its $141 million Series B round of funding in January. Hippocratic AI’s generative AI solution focuses on nondiagnostic healthcare tasks such as medication onboarding and monthly reconciliation, hospital and payor policy questions, and EHR assistance.  The company …

Navina, an AI-enabled clinical intelligence platform for primary care providers, announced the close of a $55 million Series C funding round, bringing its total raise to $100 million.  Growth Equity at Goldman Sachs Alternatives led the round, with participation from existing investors Vertex Ventures Israel, ALIVE and Grove Ventures. WHAT IT DOES Navina offers providers, accountable care organizations, management services …

Cardiometabolic digital diagnostics company Nanowear announced a licensing and data partnership with glucose monitoring specialist Dexcom to integrate glucose data from the Dexcom G7 into its SimpleSense nanotechnology-enabled wearable.  Nanowear offers home-based, AI-enabled digital diagnostics for cardiometabolic health. The company’s FDA-cleared SimpleSense wearable reads patient vitals, such as respiration rate, heart rate, blood pressure, physical activity, lung volume and more. …

Infusion and chronic care management company Uptiv Health announced a partnership with the automation platform Lamar Health to implement AI-powered automation for referral intake and prior authorization processes. Uptiv offers infusion therapy for patients with chronic conditions via a hybrid model that merges customized in-clinic care with a digital platform.  In addition to traditional infusion services, Uptiv provides care coordination, …

Health technology company Royal Philips has expanded its partnership with Ibex Medical Analytics that includes a new release of the Philips IntelliSite Pathology Solution (PIPS) to speed up adoption of AI-enabled digital pathology tools.  In 2021, Philips and Ibex combined PIPS with Ibex’s Galen AI-powered cancer diagnostics platform.  The agreement then was aimed at helping pathologists generate objective, reproducible results, …

Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study multiple novel therapeutic treatment arms for women with newly diagnosed, locally advanced breast cancer.  A platform trial is a clinical trial design that allows for the …

Amboss, a medical education company for medical students and healthcare stakeholders, closed a €240 million ($259.44 million) financing round. The round included new primary investors KIRKBI, M&G Investments and Lightrock, with participation from existing shareholders. The company recently converted to a European stock corporation (SE).  WHAT IT DOES Amboss helps medical students and professionals access information. Its platform includes a …

As we move into spring, protection from any earlier COVID-19 vaccination you may have had will be starting to wane. COVID-19 can still be very dangerous and even life threatening, particularly for older people and those with a weakened immune system. Thankfully, for those who are more likely to become seriously ill from COVID-19, the NHS offers a free vaccine …

Aura, an AI-enabled digital protection platform, announced it officially closed its Series G funding round, raising $140 million in equity and debt and bringing its valuation to $1.6 billion. The round initially closed in August 2024. Ten Eleven Ventures and Madrone Capital led the round, with participation from new investor AT&T Ventures. Existing investors General Catalyst, Warburg Pincus and Accel …

Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles, located on the surface of a Vero E6 cell The UK Health Security Agency (UKHSA) was set up to protect health from infectious diseases and environmental hazards. We prepare for future threats to prevent health and socioeconomic impacts and although there are hundreds of pathogens that can cause disease in humans, we …